And, even though Chip denied this on the conference call, one of the big banks (I want to say Lehman) stated in a report that Tercica provided one month of treatment free of charge.
In the January CC there was an intimation of this. I came away with that impression, but I can't quote chapter and verse and am unwilling to listen again (even if it were available.) Bottom-line, I think something like a one-month "sample" is part of their marketing plan.
BTW, I don't think the Endo conference is going to do much in a permanent way for the sp. It's all in the sales numbers at this point. We went up today not in spite of Tercica, but becasue TRCA si showing some traction, so the street is thinking that there may be a market here after all.
Regards,
Bob
Market Data 
Markets 
AI
